European Neuroendocrine Tumor Society

European Neuroendocrine Tumor Society

Open Access statistics for European Neuroendocrine Tumor Society, Germany, covering academic research published from 2001 to 2023.

Open Access statistics for European Neuroendocrine Tumor Society, Germany, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

44%


Total
Publications

452


Total Open
Publications

197


Total
Citations

4.2K


Open Access
Percentage

44%


Total
Publications

452


Total Open
Publications

197


Total
Citations

4.2K

Website

download

Breakdown

14% 22% 8% 56%

Publisher Open

14%

Both

22%

Other Platform Open

8%

Closed

56%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

39

Hybrid 49%

79

No Guarantees 27%

44

Other Platform Open

Domain 60%

79

Institution 48%

64

Preprint 30%

40

Other Internet 17%

23

Public 3%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
73
Research Square
Preprint
50
Europe PMC
Domain
37
Würzburg University - Online Publication Service of Würzburg University
Institution
22
Augsburg University - OPUS - Augsburg University Publication Server
Institution
12
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
10
Unknown Repository
Other Internet
9
ZB MED - Informationszentrum Lebenswissenschaften - PUBLISSO-Fachrepositorium Lebenswissenschaften
Other Internet
6
Ludwid Maxmilian's Universitat Munchen - Open access LMU
Institution
6
Technische Universität München - mediaTUM Gesamtbestand
Institution
5
1 / 7

Data updated 17 June 2024

Share

Share

Share